Historical shareholding details of Bridgeway Capital Management, LLC holdings in AN2 Therapeutics Inc (ANTX)

Monthly changes of Bridgeway Capital Management, LLC shareholding in AN2 Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Bridgeway Capital Management, Llc 161,300 0.54%
Jan 31, 2025 Bridgeway Capital Management, Llc 161,300 0.54%
Dec 31, 2024 Bridgeway Capital Management, Llc 162,200 0.54%
Dec 31, 2024 Bridgeway Capital Management, Llc 194,500 0.65%
Nov 30, 2024 Bridgeway Capital Management, Llc 194,500 0.65%
Oct 31, 2024 Bridgeway Capital Management, Llc 194,500 0.65%
Sep 30, 2024 Bridgeway Capital Management, Llc 197,000 0.66%
Sep 30, 2024 Bridgeway Capital Management, Llc 101,792 0.34%
Aug 31, 2024 Bridgeway Capital Management, Llc 101,792 0.34%
Jul 31, 2024 Bridgeway Capital Management, Llc 101,792 0.34%
Jun 30, 2024 Bridgeway Capital Management, Llc 104,292 0.35%
Jun 30, 2024 Bridgeway Capital Management, Llc 23,792 0.08%
May 31, 2024 Bridgeway Capital Management, Llc 23,792 0.08%
Apr 30, 2024 Bridgeway Capital Management, Llc 34,492 0.12%
Mar 31, 2024 Bridgeway Capital Management, Llc 26,292 0.09%
Mar 31, 2024 Bridgeway Capital Management, Llc 34,492 0.12%
Feb 29, 2024 Bridgeway Capital Management, Llc 45,000 0.15%
Jan 31, 2024 Bridgeway Capital Management, Llc 45,000 0.15%
Dec 31, 2023 Bridgeway Capital Management, Llc 36,992 0.12%
Dec 31, 2023 Bridgeway Capital Management, Llc 45,000 0.15%
Nov 30, 2023 Bridgeway Capital Management, Llc 45,000 0.15%
Oct 31, 2023 Bridgeway Capital Management, Llc 25,000 0.08%
Sep 30, 2023 Bridgeway Capital Management, Llc 47,500 0.16%
Sep 30, 2023 Bridgeway Capital Management, Llc 25,000 0.08%
Aug 31, 2023 Bridgeway Capital Management, Llc 25,000 0.08%
Jul 31, 2023 Bridgeway Capital Management, Llc 50,000 0.26%
Jun 30, 2023 Bridgeway Capital Management, Llc 27,500 0.09%
Jun 30, 2023 Bridgeway Capital Management, Llc 50,000 0.26%
May 31, 2023 Bridgeway Capital Management, Llc 50,000 0.26%
Mar 31, 2023 Bridgeway Capital Management, Llc 52,500 0.27%

View all ownership details of AN2 Therapeutics Inc